In May 2023, transgender youths and their families gathered outside the Supreme Court. The rally followed the Trans Youth Prom event in Washington, DC. The protest expressed concerns over a new policy impacting gender-affirming care.
The Trump administration has finalized a healthcare policy forbidding federal funding for gender-affirming care for children on Medicaid or the Children’s Health Insurance Program. A.W., a California mother of a transgender teenager, voiced her distress over the news. She expressed fears for her family, worried about potential targeting under the new rule.
This regulation affects a small number of the population. KFF, a health research organization, estimates 130,000 transgender individuals under 18 live in states where gender-affirming care remains available, despite many states banning it. A.W.’s family relies on Medicaid after losing private health benefits.
A.W. identifies as a longtime Republican but admits her family needs this assistance due to current circumstances. The rule was expected as it was proposed in December, but its publication still caused panic and uncertainty for families like hers.
Katie Keith, director of the Center for Health Policy and the Law at Georgetown, describes the rule as ‘unprecedented.’ It marks a significant federal action targeting a specific patient group.
Lindsey Dawson from KFF indicates the potential impact depends on state responses. Some states might choose to fund the care neglected by federal support, but clarity is lacking in terms of which states will take this step.
“When the harms of sex-rejecting procedures are so serious and the evidence is weak, the government cannot keep signing these checks,” explained Dr. Mehmet Oz on social media.
The Trump administration also released a report, “Wolves in White Coats,” featuring detransitioned youths and accusations against healthcare providers. None involved in drafting the report are government staff, many have anti-trans ties.
The administration refers healthcare providers for investigations over alleged fraudulent practices, echoing these sentiments in a related documentary.
Dawson points out this administration’s dual approach of formal policy and rhetoric stokes fear among healthcare providers, leading some to end gender-related programs.
A.W. criticizes the administration’s focus, describing it as an unnecessary obsession. Her family’s journey with their child started with subtle signs of trans identity, leading to supportive healthcare steps. She appreciates the comprehensive care from California’s Medicaid program, countering allegations of healthcare provider greed.
President Trump acknowledged his role in the policy’s direction, hinting at its implication for upcoming elections. A.W. calls this political maneuvering heart-wrenching, seeing her child as a pawn in political struggles.
Legal challenges to the rule are expected. Jennifer Levi, senior attorney at GLAD Law, views it as part of a broader assault on transgender rights, noting various government actions targeting the community.
Some Democratic states oppose the rule and plan to substitute the lost funding, although the practical execution could be challenging, according to Georgetown’s Keith.
A.W. is relieved that California plans to continue supporting gender-affirming care but remains concerned about broader implications for her son. These include travel restrictions and general safety for trans individuals.
This situation creates a significant burden on families like hers. They constantly navigate uncertainties for their children’s well-being, striving to allow them to thrive.